These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7166178)

  • 1. Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites.
    Pentikäinen PJ; Penttilä A; Neuvonen PJ; Khalifah RG; Hignite CE
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):259-67. PubMed ID: 7166178
    [No Abstract]   [Full Text] [Related]  

  • 2. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man.
    Pentikäinen PJ; Tokola O; Alhava E; Penttilä A
    Eur J Clin Pharmacol; 1984; 27(3):349-54. PubMed ID: 6334608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.
    Pentikäinen PJ; Neuvonen PJ; Backman C
    Eur J Clin Pharmacol; 1981; 19(5):359-65. PubMed ID: 7238564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.
    Karjalainen MJ; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2007 Sep; 63(9):829-36. PubMed ID: 17618427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.
    Stenderup J; Eriksen J; Pedersen SB; Christiansen LV
    Eur J Clin Pharmacol; 1985; 28(5):573-9. PubMed ID: 3876221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tolfenamic acid and its detection time in urine after intravenous administration of the drug in camels (Camelus dromedarius).
    Wasfi IA; ElGhazali M; Hadi AA; Zorob O; Boni NS; Alkatheeri NA; Barezaiq IM
    Am J Vet Res; 1998 Nov; 59(11):1451-8. PubMed ID: 9829406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease.
    Láznícek M; Senius KE
    Eur J Clin Pharmacol; 1986; 30(5):591-6. PubMed ID: 3758148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose.
    Niopas I; Georgarakis M; Sidi-Frangandrea V; Chrisanthopoulos C; Liara E
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):293-6. PubMed ID: 8983935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks.
    Tokola RA; Kangasniemi P; Neuvonen PJ; Tokola O
    Cephalalgia; 1984 Dec; 4(4):253-63. PubMed ID: 6394143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review.
    Feldman D; Leahy E; Lee SH
    Curr Med Chem; 2018; 25(14):1598-1608. PubMed ID: 28413959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid downregulates β-catenin in colon cancer.
    Ha T; Lou Z; Baek SJ; Lee SH
    Int Immunopharmacol; 2016 Jun; 35():287-293. PubMed ID: 27089389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolfenamic acid and caffeine: a useful combination in migraine.
    Hakkarainen H; Parantainen J; Gothoni G; Vapaatalo H
    Cephalalgia; 1982 Dec; 2(4):173-7. PubMed ID: 6984358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolfenamic Acid.
    Ahmed S; Sheraz MA; Ahmad I
    Profiles Drug Subst Excip Relat Methodol; 2018; 43():255-319. PubMed ID: 29678262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolfenamic acid decreases migraine recurrence when used with sumatriptan.
    Krymchantowski AV; Adriano M; Fernandes D
    Cephalalgia; 1999 Apr; 19(3):186-7. PubMed ID: 10234467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid.
    Subaiea GM; Ahmed AH; Adwan LI; Zawia NH
    J Alzheimers Dis; 2015; 43(2):425-33. PubMed ID: 25096618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histochemical demonstration of the oxidation of 3-hydroxyanthranilate (author's transl)].
    Mello De Oliveira JA; Vannucchi H
    Cell Mol Biol Incl Cyto Enzymol; 1977; 22(1):147-50. PubMed ID: 606356
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of tolfenamic acid following two oral dose levels in buffalo calves.
    Dinakaran V; Dumka VK
    J Vet Pharmacol Ther; 2013 Jun; 36(3):306-8. PubMed ID: 23146086
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of tolfenamic acid in the prevention of migraine].
    Vaitkus A; Pauza V
    Medicina (Kaunas); 2002; 38(3):296-303. PubMed ID: 12474702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.